Alpha Centric Advisors LLC Bio Rad Laboratories, Inc. Transaction History

Alpha Centric Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$351.71 - $456.01 $597,907 - $775,217	1,700 Added 100.0%	3,400 $1.43 Million
Q3 2022 Nov 08, 2022	BUY	$412.59 - $563.26 $701,403 - $957,542	1,700 New	1,700 $709,000
Q4 2021 Feb 25, 2022	SELL	$708.84 - $794.68 $75,137 - $84,236	-106 Closed	0 $0
Q3 2021 Mar 09, 2022	SELL	$657.71 - $825.77 $42,751 - $53,675	-65 Reduced 38.01%	106 $79,000
Q2 2021 Mar 09, 2022	BUY	$576.64 - $649.04 $8,072 - $9,086	14 Added 8.92%	171 $110,000
Q1 2021 Mar 09, 2022	SELL	$547.01 - $662.35 $1,641 - $1,987	-3 Reduced 1.88%	157 $90,000
Q4 2020 Mar 11, 2022	BUY	$510.68 - $643.45 $49,025 - $61,771	96 Added 150.0%	160 $93,000
Q2 2020 Mar 11, 2022	BUY	$334.87 - $493.06 $21,431 - $31,555	64 New	64 $29,000

458

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.48B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.